Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 2	2026-07-07		NCT06552234

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer	24
Groupe Francais De Pneumo-Cancerologie	7
Hospices Civils de Lyon	429

20 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AP-HM	Marseille	France	1
Centre François Baclesse	Caen	France	39
CH Aix-en-Provence	Aix-en-Provence	France	1
CH Chambéry	Chambéry	France	4
CH Cornouaille	Quimper	France	5
CHD Vendée	La Roche-sur-Yon	France	41
CHI Créteil	Créteil	France	7
CHRU Lille	Lille	France	32
CHU Angers	Angers	France	87
CHU Bordeaux	Bordeaux	France	67
CHU Brest	Brest	France	37
CHU Limoges	Limoges	France	42
CHU Rennes	Rennes	France	57
CHU Rouen	Rouen	France	49
CHU Toulouse	Toulouse	France	76
HIA Sainte Anne	Toulon	France	1
Hospices Civils de Lyon	Lyon	France	43
Hôpital Foch	Suresnes	France	27
Hôpitaux Civils de Colmar	Colmar	France	5
Hôpitaux Nord-Ouest	Villefranche-sur-Saône	France	1

Clinical trials